NIH-funded research R01 grant

Understanding how Brucella gene silencing affects its ability to cause disease

Official title: Determining the molecular basis of gene silencing by MucR and defining its role in Brucella virulence

Funded at East Carolina University · NIH-11377343 · Data updated 2026-11-12

Scientists are studying Brucella bacteria to uncover how a protein called MucR helps the bacteria turn off genes and how this affects its ability to cause illness in animals and people.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEast Carolina University
NIH-funded
Lab location1 site (Greenville, United States)
Project startJuly 14, 2023
Project endJune 30, 2027
Funding year2026
Award (this year)$581,515
NIH project number5R01AI172822-04
Project IDNIH-11377343 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals or communities in which Brucella infection is a concern, and future work may inform vaccines or therapies.

Less likely to help

People without Brucella exposure or those not involved in disease research would not directly benefit.

What this research studies

Brucella infections are a major global health concern, especially where animal brucellosis is common. Researchers will use genetic and biochemical methods to test whether MucR acts like a gene silencer and to identify other factors that can counter this silencing. The project will also examine whether the coordinated control of virulence genes by MucR and counter-silencers is necessary for the bacteria to cause disease in mice and in cultured cells. This work could reveal new targets to interrupt Brucella’s infection process. The study is conducted at East Carolina University under the PI Roy M. Roop.

Why it matters

Potential benefit: If successful, the research could point to new strategies to prevent or treat Brucella infections in animals and reduce human risk.

How similar studies have gone: Previous work has shown MucR’s role in virulence regulation, with potential for translating findings into interventions in Brucella infections.

Where this research is happening

  • East Carolina University
    Greenville, United States
    Active

Researchers

  • Principal investigator: Roop, Roy M — East Carolina University
  • Study coordinator: Roop, Roy M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.